AI Jolts Crypto, Misinformation Risk, Debate at CES, Pharma's Future
How AI is Sparking Promise and Controversy Across Crypto, Public Discourse, Consumer Tech, and Healthcare
AI Tokens Soar with Gains Up to 650% as Funding Surges
- AI coins saw 650% gains in 2023, massively outperforming BTC and ETH
- Rising interest in AI amid ChatGPT popularity driving token price surge
- Funding for Web3 AI projects jumped to $298M in 2023, up from $148.5M prior 7 years
- Tangible use cases and funding growth indicates long-term potential for AI crypto
AI-Powered Misinformation Deemed Top Near-Term Threat in Davos Report
- False information powered by AI seen as #1 short-term global economic risk
- As generative AI spreads, synthetic content could undermine democracy
- Comes as billions worldwide head into major election cycles
- Longer-term, environmental threats like extreme weather top concerns
HEADLIME IS THE GO-TO GPT-3 TOOL FOR MARKETERS.
WRITESONIC IS ONE OF THE BEST ARTIFICIAL INTELLIGENCE-POWERED COPYWRITING GPT-3 TOOLS.
AI Takes Center Stage at CES 2023
- AI featured across devices/gadgets at CES, from fridges to self-driving cars
- Anthropic's Claude aims to ease AI anxiety as adoption proliferates
- But AI risks like fake news still worry some unprepared for societal impact
- Beyond AI, big screens, phones, gaming tech also debuted
- Goal to spark debate around democratizing access to increasingly ubiquitous AI
DeepMind Aims to Halve Drug Discovery Time with AI
- DeepMind believes its Isomorphic Labs can halve initial drug discovery to 2 years
- Comes after $3B deals with pharma giants Eli Lilly and Novartis
- Platform uses AI to predict biochemical structures and identify promising compounds
- With average drug development taking 10 years/$2.7B, industry seeks innovation
- Isomorphic's focus on biology/chemistry models distinguishes its AI approach
AI Tokens Soar with Gains Up to 650% as Funding Surges
Binance Research found that artificial intelligence (AI) coins saw much higher gains in 2023 than bitcoin and ethereum, with the top 5 AI tokens gaining between 200-650%. This massive performance is attributed to rising interest in the AI sector amid the popularity of chatbots like ChatGPT. Subsequently, AI has started to reshape crypto, with increasing real-world use cases. Funding for Web3 AI projects also jumped dramatically in 2023 to $298 million, more than the previous 7 years combined. While AI crypto projects are still early-stage, the tangible use cases and funding growth point to long-term potential. Overall, 2023 saw AI tokens massively outperform top cryptos as interest and investment flooded into the space.
AI-Powered Misinformation Deemed Top Near-Term Threat in Davos Report
The World Economic Forum's latest Global Risks Report finds that false and misleading information amplified by advanced AI poses the greatest immediate danger to the global economy. As generative AI like ChatGPT becomes more accessible, the report warns that manipulating public opinion through synthetic content could erode democracy and divide society. This risk looms as billions worldwide head to elections. Longer-term, environmental threats like extreme weather, biodiversity loss, and resource scarcity are seen as the biggest risks over the next decade. The report casts AI as a dual-edged sword, also making cyberattacks easier to automate. With public trust and climate stability at stake, curbing the harms of AI-powered disinformation is deemed critical in the near future
AI Takes Center Stage at CES 2023
Artificial intelligence was the main attraction at the 2023 Consumer Electronics Show (CES) in Las Vegas, featured in many new gadgets and devices. From AI-powered fridges to self-driving cars, AI is becoming embedded across areas of daily life. Anthropic's voice assistant Claude aimed to ease AI anxiety with its friendly, supportive presence. However, questions linger around ethics and potential misuse. While attendees marveled at the convenience of AI, risks like cyberattacks and fake news left some unsure society is prepared. As AI proliferates behind the scenes, CES organizers hoped to spark discussion around democratizing access. With over 4,000 exhibitors and 110,000 attendees, CES 2023 moved past pandemic restrictions. Though AI stole the spotlight, big screens, phones, gaming tech and more also debuted. The verdict: AI is an inescapable reality with pros and cons that requires open debate.
DeepMind Aims to Halve Drug Discovery Time with AI
DeepMind co-founder Demis Hassabis believes the company's drug discovery spinout, Isomorphic Labs, can reduce the initial drug discovery stage from 5 years to 2 using AI. This bold target comes after Isomorphic announced deals with pharma giants Eli Lilly and Novartis worth up to $3 billion combined. Hassabis said Isomorphic's AI platform can predict biochemical structures to streamline identifying promising compounds. With average drug development taking a decade and $2.7 billion, pharma urgently needs innovation. While interest and funding in AI drug discovery balloons, Isomorphic claims its focus on fundamental biology and chemistry models makes it unique. With its partners eager for new assets, DeepMind hopes its AI can significantly quicken the arduous, costly drug creation process. Though past AI drug failures prove it's not foolproof, Hassabis sees much promise in generative AI to revolutionize the field.